Professor Lyu is the Dean of the First Hospital of Jilin University and Bethune First Medical Colleague of Jilin University, Director of the General Surgery Center at the First Hospital of Jilin University.

Prof. Lyu has published more than 100 in high-level peer-reviewed SCI-indexed journals such as the Journal of Hepatology, Gut, Hepatology, Nature Communications, and American Journal of Transplantation. In addition, he has participated in the compilation of 3 monographs and obtained 11 invention patents. Prof. Lyu has undertaken more than 20 state- and provincial-level projects in China, with a total funding amount of more than 20 million RMB.

He is one of the Editors-in-Chief of a new international journal named eGastroenterology. The journal was launched in July 2023, with global distribution and publication overseen by BMJ.

Professor Matías A. Avila, is the Co-Director of the Solid Tumors Program at the Center for Applied Medical Research (CIMA) at the University of Navarra, Spain. His research focuses on liver injury, regeneration, tumorigenesis, hepatoprotective strategies for liver failure, and molecular targets for liver tumor diagnosis and treatment.

Prof. Avila has published over 120 papers and has an h-index of 60. He served as Associate Editor of the Journal of Hepatology from 2019 to 2023 and is currently an Associate Editor for Gut. He has also been a member of the editorial boards of Gastroenterology, Hepatology, Clinical Science, Liver International, and PLoS One.

He was a member of the EASL Governing Board and the Spanish Association for the Study of the Liver (AEEH), and also on the Scientific Advisory Boards of the Cochin Institute and the Center for Research in Inflammation (CRI) at INSERM, Paris.

Professor Bin Gao is the Deputy Scientific Director and Chief of the Laboratory of Liver Diseases at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. His research focuses on liver immunology, biology, and the pathogenesis of fatty liver diseases, liver cancer, and metabolic syndrome.

Prof. Gao's group has developed advanced mouse models to study these conditions, leading to significant insights into liver injury, repair, and potential treatments. Notably, his team identified interleukin-22 (IL-22) as a crucial survival factor for liver cells, which has contributed to ongoing clinical trials for treating severe alcoholic hepatitis and liver failure.

Prof. Gao has published more than 350 papers and has an h-index of 118. Currently, he serving on the Associate Editors for Seminars in Liver Diseases, Cellular & Molecular Immunology, International Journal of Biological Science, eGastroenterology, and as the Editorial board for Journal of Clinical Investigation, Gastroenterology, Gut, Journal of Hepatology, Hepatology etc.

Professor Wen-Xing Ding is a Professor in the Department of Pharmacology at the University of Kansas Medical Center. Since 2009, his laboratory has focused on the role of autophagy in alcohol and drug-induced liver injury. Prof. Ding has published over 170 papers in peer-reviewed journals and has an h-index of 74. He served as a co-chair for the Gordon Research Conference on Alcohol-Induced End Organ Injury in 2019. Additionally, he is an Associate Editor for Autophagy and serves on the editorial boards of Hepatology, Scientific Reports, American Journal of Pathology, and eGastroenterology.

Professor Huiping Zhou is a Professor in the Department of Immunology and Microbiology at Virginia Commonwealth University. Her research primarily focuses on ER stress, inflammation, bile acids, and sphingosine 1-phosphate signaling in liver diseases. She investigates metabolic dysfunction-associated fatty liver disease (MAFLD), alcoholic liver disease, and biliary pathophysiology. Prof. Zhou has made significant contributions to the field, having published over 170 peer-reviewed papers, review articles, and book chapters, and her h-index is 68.

Professor Cynthia Ju (Changqing) is a Professor at The University of Texas Health Science Center at Houston. Her research primarily focuses on understanding the inflammatory mechanisms underlying both acute and chronic liver diseases, which affect more than 30 million Americans. Although liver disease can arise from various etiologies, including viral infections, drug treatments, alcohol consumption, and metabolic disorders, tissue inflammation remains a central driver of disease progression. Currently, Prof. Ju and her team are investigating the role of hypoxia-inducible factors (HIFs) in mediating the hepatoprotective functions of hepatic macrophages. She is also a member of the editorial board of eGastroenterology.

Dr. Adrien Guillot is a Junior Research Group Leader at Charité University Medical Center in Berlin. His research focuses on characterizing the liver immune microenvironment and the interactions between immune and parenchymal cells during chronic liver diseases. He employs innovative technologies such as multiplex immunostaining and digital image analysis approaches, as well as elaborate primary cell culture systems.

Professor Frank Tacke is the Chairman of Hepatology and Gastroenterology at Charité University Medical Center in Berlin. His research interests are including hepatitis, liver diseases, and gastrointestinal disorders. Prof. Tacke has published over 350 peer-reviewed articles that have garnered more than 10,000 citations, and his h-index is 128. He is a member of the editorial boards of Hepatology, Gastroenterology, and Nature Reviews Gastroenterology & Hepatology, and as an Associate Editor for eGastroenterology. Additionally, he holds memberships in several professional societies, including the American Association for the Study of Liver Diseases (AASLD), the European Academy for Tumor Immunology, the International Liver Transplantation Society (ILTS), and the European Association for the Study of the Liver (EASL).

Zhaoli Sun is a Professor of Surgery in Johns Hopkins University School of Medicine and also the Director of the Transplant Biology Research Center in Johns Hopkins University School of Medicine. His research area mainly focuses on transplant.

Sun is a member of the editorial board of Hepatology, Pharmacology Research, Human Immunology and BBA-Molecular Basis of Disease, and Gastroenterology, World Journal of Gastroenterology, Journal of Pharmacological Science， Journal of Clinical Investigation, and eGastroenterology.

Professor Emad El-Omar is the Chair of Medicine at St George & Sutherland Clinical School, University of New South Wales (UNSW) in Sydney, Australia. Additionally, he serves as the Editor-in-Chief of the journal Gut and as an Advisor for eGastroenterology. Prof. El-Omar is a Member of the Association of Physicians of Great Britain and Ireland, a Fellow of the Royal Australasian College of Physicians, a Member of the American Gastroenterological Association, and a Member of the British Society of Gastroenterology.

His research focuses on the microbiome, inflammation-driven gastrointestinal cancer, and inflammatory bowel disease. As the Director of the UNSW Microbiome Research Centre (MRC) at St George Hospital, he oversees a global network of over 100 research projects. He has published 13 book chapters and more than 300 papers in prestigious journals, with an h-index of 82.

Professor William Grady is a Professor in both the Translational Science and Therapeutics Division and the Public Health Sciences Division at Fred Hutch. His work is dedicated to discovering innovative approaches to prevent, detect, and treat colon cancer and other gastrointestinal (GI) cancers.

A molecular biologist by training, Prof. Grady focuses on identifying molecular markers, or biomarkers, that can be easily detected in blood or stool samples. These biomarkers have the potential to be developed into widely accessible tests for early cancer detection, when the disease is most treatable, or for identifying healthy tissues at high risk of becoming cancerous. By leveraging such biomarkers, doctors could customize cancer prevention tests and therapies for those at greatest risk.

In addition to his research, Prof. Grady is a prominent leader in national research groups within his field. He also practices as a gastroenterologist, providing care for patients with GI cancers, precancers, and genetic conditions that increase their risk of developing GI cancers. He has published around 400 peer-reviewed articles and has an h-index of 73. Currently, he serves as Deputy Editor of Gut, and Associate Editor of eGastroenterology.

Dr. Ni is an Associate Professor in the Department of Pharmacology, Toxicology, and Therapeutics at the University of Kansas Medical Center. Her research interests include exploring novel mechanisms in lipid metabolism regulation, NAFLD, and obesity, as well as investigating necroptosis in hepatic ischemia-reperfusion injury and autophagy in alcohol- or drug-induced liver injury and tumorigenesis.

In addition to her research, Dr. Ni serves as the Technical Director of the Liver Cell Isolation Core within the department. In this role, she trains staff and oversees the isolation of primary hepatocytes and non-parenchymal cells from human, mouse, and rat sources. The Core supports various NIH-funded projects, publications, and grant applications.

Dr. Honglei Weng is a Senior Scientist in the Department of Medicine at Heidelberg University, Germany. His research focuses on the molecular mechanisms underlying fibrosis and cirrhosis in chronic liver diseases and their role in the development of primary liver cancers, such as hepatocellular carcinoma and cholangiocarcinoma. He has published approximately 80 peer-reviewed articles.

John Harmon is a Professor of Surgery and directs the Surgical Research Program at Johns Hopkins Bayview, within the Hendrix Burn/Wound Laboratory. He is also the Editor-in-Chief of eGastroenterology.

His clinical focus includes resections for cancers of the stomach, esophagus, colon, and pancreas. His recent research centers on esophageal cancer, using a rat model to study adenocarcinoma and the role of the Hedgehog pathway in Barrett’s esophagus. He has published over 400 papers with an h-index of 53.

Prof. Harmon also explores the use of endogenous stem cells for tissue regeneration and has collaborated with Dr. Gregg Semenza on the role of Hypoxia-Inducible Factor 1 (HIF-1) in wound repair. Dr. Semenza received the 2019 Nobel Prize for his work on HIF-1.

Professor Thomas Rösch is the Director of the Department of Endoscopy at Hamburg University Medical Center and serves as Deputy Editor of Gut.

He has made significant contributions to the development of endoscopic ultrasound and both diagnostic and therapeutic endoscopy. Prof. Rösch is highly acclaimed for his exceptional endoscopic skills and research, receiving recognition both nationally and internationally. He is frequently invited to speak at major conferences and professional events across the Americas, Asia, and Europe.

He has published extensively on new endoscopic diagnostic and therapeutic methods in top international journals, including New England Journal of Medicine, Gastroenterology, Gut, American Journal of Gastroenterology, and Gastrointestinal Endoscopy.

Professor Junqi Niu is a Chief Physician, Head of Department of Hepatobiliary and Pancreatic Medicine of the First Hospital of Jilin University.

Prof. Niu worked as Visiting Fellow in the Department of Medicine, St. Mary’s Hospital, University of London in 1994, and employed as Senior Visiting Fellow at Department of Medicine, University of Connecticut Health Center, School of Medicine in 1999.

Prof. Niu’s main research interests include hepatitis B and C, hepatocellular cancer, liver fibrosis and cirrhosis, epidemiology, therapeutic clinical trials for chronic hepatitis B and C, as well as other chronic liver diseases as cause of liver cancer such as non-alcoholic fatty liver disease.

Prof. Niu has two patents and taken charge of more than 25 state- and provincial-levels projects in China, with the total funding amount of more than 20.76 million. He is the Co-Editor-in-Chief of a Chinese journal Journal of Clinical Hepatology and holds editorial positions in journals such as Chinese Journal of Infectious Diseases, Chinese Journal of Hepatology, and Hepatobiliary & Pancreatic Diseases International, and also is the Executive Editor of eGastroenterology.

Professor Yanhang Gao is a Chief Physician and Director of the Department of Hepatobiliary and Pancreatic Medicine of the First Hospital of Jilin University.

Prof. Gao was a visiting scholar at NIH/NAAA in the USA. Prof. Gao's clinical and basic research are related to alcoholic liver disease and late-stage clinical trials of new drugs for chronic viral liver diseases. Her research works have been published in Gut, Journal of Hepatology, Clinical infectious diseases, Liver Int, and IJBS. Prof. Gao has taken charge of more than 5 state-levels projects in China. She is the Co-Editor-in-Chief of a Chinese journal Journal of Clinical Hepatology and served on the editorial board of several international medical journals include eGastroenterology.

Professor Hua Wang is the Deputy Director of the Research Office at Anhui Medical University and the Inflammation and Immune Mediated Diseases Laboratory of Anhui Province. Additionally, he is the Chief of the Division of Tumor Immunotherapy in the Department of Oncology and the Director of the Biobank at the First Affiliated Hospital of Anhui Medical University.

Prof. Wang has been recognized as an Excellent Young Scientist and Distinguished Young Scholar by the National Natural Science Foundation of China (NSFC). He serves as a regular reviewer for leading journals such as Hepatology, Journal of Hepatology, and Liver International. Additionally, he holds senior editorial positions for several journals, including Chief Editor of Gene Expression and Editorial Board Member of the Journal of Clinical and Translational Hepatology and eGastroenterology. Prof. Wang has been honored with the Anhui Provincial Youth Science and Technology Award and the Wu Mengchao Youth Award for his outstanding contributions to science and technology.

His research focuses on liver injury, inflammation, and repair. Prof. Wang has published over 100 peer-reviewed articles in prestigious journals, including Cell Host & Microbe, Cell Metabolism, Gastroenterology, Hepatology, Journal of Hepatology, Nature Communications and so on. He has an h-index of 61 and his work has been cited more than 12,580 times.

Professor Lin Wang is the Director of the Hepatobiliary Surgery Department at Xijing Hospital.

He has received several prestigious awards, including the National Science Fund for Distinguished Young Scholar, the National Science Fund for Excellent Young Scientist, the first batch of Youth Changjiang Scholars from the Ministry of Education, the National Ten Thousand Talents Program for Young Top Talents, and has been a principal investigator for the National Key Research and Development Program.

Prof. Wang is a committee member of the American Association for the Study of Liver Diseases (AASLD), a Youth Committee member and Liver Disease Group member of the Chinese Medical Association Surgical Branch, and a member of the Chinese Digestive Surgery Elite Forum.

He has published as a corresponding author in top journals such as Cell Metabolism, Nature Aging, Nature Communications, Journal of Clinical Investigation, Gastroenterology, Hepatology, and STTT.

Professor Minghua Zheng is the Deputy Director of the Department of Infectious Diseases and a Chief Physician at the First Affiliated Hospital of Wenzhou Medical University. He has long been dedicated to the clinical management and research of fatty liver disease, specializing in the diagnosis and treatment of common and complex liver diseases, including fatty liver, hepatitis B, hepatitis C, and autoimmune hepatitis.

Vikesh Singh is currently a Professor of Medicine and Director of Pancreatology, where he oversees the Pancreatitis Center and the Islet Autotransplantation Programs. He is also the Director of Endoscopy at Johns Hopkins Hospital. He serves as a member of the Board of Directors of the National Pancreas Foundation, Chair of the Pancreatic Disorders Section of the American Gastroenterological Association, Councilor for the International Association of Pancreatology, and a member of the inaugural Medical Advisory Board for the Familial Chylomicronemia Syndrome (FCS) Foundation, and an Associate Editor for eGastroenterology.

Prof. Singh's research focuses on the medical and endoscopic evaluation and treatment of inflammatory disorders of the pancreas. He has published over 420 peer-reviewed articles, which have garnered more than 11,500 citations, and his h-index is 66.

Dr. Menghan Gao is the Managing Editor of eGastroenterology. She holds a Master’s degree in Public Health from Stockholm University and a Ph.D. in Epidemiology from Karolinska Institutet, Sweden. Prior to that, she earned both her bachelor’s and master’s degrees in Law from Jilin University.

As an epidemiologist, Dr. Gao has published several research papers in leading journals such as Clinical Infectious Diseases, International Journal of Epidemiology, and American Journal of Obstetrics & Gynecology . She has also contributed commentary articles to The Lancet and The Lancet Global Health.

Since joining The First Hospital of Jilin University in 2022, Dr. Gao has been dedicated to the launch and development of eGastroenterology. Her efforts in academic publishing have earned her funding and recognition through various prestigious programs.

Dr. Jidong Jia is a Chief Physician, Professor, and Director of the Liver Disease Research Center at Beijing Friendship Hospital, Capital Medical University. Dr. Jia currently serves as a member of the Hepatology Branch of the Chinese Medical Association, a standing committee member of the Clinical Pharmacy Branch of the Chinese Medical Association, and Vice Chairman of the Hepatitis Prevention and Treatment Foundation of China, among other social organization roles. His previous roles include Chairman of the Hepatology Branch (2006–2012) and President of both the Asian Pacific Association for the Study of the Liver (2009–2010) and the International Association for the Study of the Liver (2015–2016).

Dr. Jia has received numerous accolades, such as the Special Government Allowance from the State Council and the May Fourth Youth Medal of Beijing. He is recognized in the "Mission Talent Program" and has been named one of the "Top 100 Leading Talents in Science and Technology in Beijing." He has played a pivotal role in formulating national hepatitis prevention strategies and has contributed to major projects under China's Five-Year Plans. Additionally, he serves as an Associate Editor of eGastroenterology.